Effects of alendronate on the Notch1‑RBP‑Jκ signaling pathway in the osteogenic differentiation and mineralization of vascular smooth muscle cells

Zhou,Shaoqiong; Fang,Xin; Xin,Huaping; Guan,Siming

doi:10.3892/mmr.2013.1489

Effects of alendronate on the Notch1‑RBP‑Jκ signaling pathway in the osteogenic differentiation and mineralization of vascular smooth muscle cells

Authors:
- Shaoqiong Zhou
- Xin Fang
- Huaping Xin
- Siming Guan
View Affiliations

Affiliations: Department of Gerontology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China
Published online on: May 24, 2013 https://doi.org/10.3892/mmr.2013.1489
Pages: 89-94

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cardiovascular disease and osteoporosis are major causes of mortality in the elderly. Alendronate, a bisphosphonate, is widely used in the treatment of osteoporosis and may be used to inhibit vascular calcification. However, its mechanisms are not completely understood. The present study aimed to explore novel signaling mechanisms behind the action of alendronate in the osteoblastic differentiation of rat aortic vascular smooth muscle cells (VSMCs). The osteoblastic differentiation of VSMCs was induced by an osteogenic medium. Using von Kossa staining and direct cellular calcium content determination, mineralization was found to be significantly increased in VSMCs induced with osteogenic medium, consistent with an enhanced alkaline phosphatase activity. Osteoblastic differentiation in VSMCs was significantly reduced by the action of alendronate in a dose‑dependent manner. In addition, the expression of Notch1 and RBP‑Jκ was significantly upregulated in VSMCs cultured with osteogenic medium at the mRNA and protein levels. The effects of Notch1‑RBP‑Jκ were inhibited by treatment with alendronate in a dose‑dependent manner. In summary, results of the current study indicate that alendronate inhibits vascular calcification through downregulation of the Notch1‑RBP‑Jκ signaling pathway.

View Figures

View References

1	United Nations. World Population Ageing. New York, USA: 2009
2	World Health Report. World Health Organization; Geneva: 2002
3	Santos LL, Cavalcanti TB and Bandeira FA: Vascular effects of bisphosphonates - a systematic review. Clin Med Insights Endocrinol Diabetes. 5:47–54. 2012. View Article : Google Scholar : PubMed/NCBI
4	Lampropoulos CE, Papaioannou I and D’Cruz DP: Osteoporosis - a risk factor for cardiovascular disease? Nat Rev Rheumatol. 8:587–598. 2012. View Article : Google Scholar : PubMed/NCBI
5	Perrini S, Natalicchio A, Laviola L, et al: Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis. Endocrinology. 149:1302–1313. 2008. View Article : Google Scholar : PubMed/NCBI
6	Mithal A: Osteoporosis in Asia: a call to action. Osteoporos Int. 23:S739–S740. 2012.
7	Yesil Y, Ulger Z, Halil M, et al: Coexistence of osteoporosis (OP) and coronary artery disease (CAD) in the elderly: It is not just a by chance event. Arch Gerontol Geriatr. 54:473–476. 2012. View Article : Google Scholar : PubMed/NCBI
8	Rhee EJ, Lee WY, Kim SY, et al: Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein. Clin Sci (Lond). 108:237–243. 2005. View Article : Google Scholar : PubMed/NCBI
9	Vattikuti R and Towler DA: Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 286:E686–E696. 2004. View Article : Google Scholar : PubMed/NCBI
10	Giachelli CM: Vascular calcification mechanisms. J Am Soc Nephrol. 15:2959–2964. 2004. View Article : Google Scholar : PubMed/NCBI
11	Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M and Dobnig H: Vascular calcification and osteoporosis - from clinical observation towards molecular understanding. Osteoporos Int. 18:251–259. 2007. View Article : Google Scholar : PubMed/NCBI
12	Price PA, Faus SA and Williamson MK: Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol. 21:817–824. 2001. View Article : Google Scholar : PubMed/NCBI
13	Skolnick AH, Osranek M, Formica P and Kronzon I: Osteoporosis treatment and progression of aortic stenosis. Am J Cardiol. 104:122–124. 2009. View Article : Google Scholar : PubMed/NCBI
14	Ylitalo R, Kalliovalkama J, Wu XM, et al: Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro. Pharmacol Toxicol. 83:125–131. 1998. View Article : Google Scholar : PubMed/NCBI
15	London GM: Bone-vascular cross-talk. J Nephrol. 25:619–625. 2012. View Article : Google Scholar : PubMed/NCBI
16	Boanini E, Torricelli P, Gazzano M, Fini M and Bigi A: The effect of alendronate doped calcium phosphates on bone cells activity. Bone. 51:944–952. 2012. View Article : Google Scholar : PubMed/NCBI
17	Keam SJ and Plosker GL: Prevention and treatment of osteoporosis in postmenopausal women. Dis Manag Health Outcome. 12:19–37. 2004. View Article : Google Scholar
18	Iwamoto J, Takeda T, Sato Y and Uzawa M: Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis. Clin Rheumatol. 23:383–389. 2004. View Article : Google Scholar : PubMed/NCBI
19	Manderfield LJ, High FA, Engleka KA, et al: Notch activation of Jagged1 contributes to the assembly of the arterial wall. Circulation. 125:314–323. 2012. View Article : Google Scholar : PubMed/NCBI
20	Kurpinski K, Lam H, Chu JL, et al: Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells. 28:734–742. 2010. View Article : Google Scholar : PubMed/NCBI
21	Morimoto M, Liu ZY, Cheng HT, Winters N, Bader D and Kopan R: Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J Cell Sci. 123:213–224. 2010. View Article : Google Scholar : PubMed/NCBI
22	Shimizu T, Tanaka T, Iso T, et al: Notch signaling induces osteogenic differentiation and mineralization of vascular smooth muscle cells: role of Msx2 gene induction via Notch-RBP-Jk signaling. Arterioscler Thromb Vasc Biol. 29:1104–1111. 2009. View Article : Google Scholar : PubMed/NCBI
23	Morrow D, Guha S, Sweeney C, et al: Notch and vascular smooth muscle cell phenotype. Circ Res. 103:1370–1382. 2008. View Article : Google Scholar : PubMed/NCBI
24	Iyemere VP, Proudfoot D, Weissberg PL and Shanahan CM: Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med. 260:192–210. 2006. View Article : Google Scholar : PubMed/NCBI
25	Sage AP, Tintut Y and Demer LL: Regulatory mechanisms in vascular calcification. Nat Rev Cardiol. 7:528–536. 2010. View Article : Google Scholar : PubMed/NCBI
26	Wang M, Wu L, Wang L and Xin X: Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780. Biochem Biophys Res Commun. 393:144–149. 2010. View Article : Google Scholar : PubMed/NCBI
27	Price PA, June HH, Buckley JR and Williamson MK: Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol. 21:1610–1616. 2001. View Article : Google Scholar : PubMed/NCBI
28	Xin H, Xin F, Zhou S and Guan S: The Wnt5a/Ror2 pathway is associated with determination of the differentiation fate of bone marrow mesenchymal stem cells in vascular calcification. Int J Mol Med. 31:583–588. 2013.PubMed/NCBI
29	Zuo C, Huang Y, Bajis R, et al: Osteoblastogenesis regulation signals in bone remodeling. Osteoporos Int. 23:1653–1663. 2012. View Article : Google Scholar : PubMed/NCBI
30	Zanotti S and Canalis E: Notch signaling and bone. IBMS BoneKEy. 8:318–327. 2011. View Article : Google Scholar
31	Doi H, Iso T, Shiba Y, et al: Notch signaling regulates the differentiation of bone marrow-derived cells into smooth muscle-like cells during arterial lesion formation. Biochem Biophys Res Commun. 381:654–659. 2009. View Article : Google Scholar : PubMed/NCBI
32	Engin FZ, Yao ZQ, Yang T, et al: Dimorphic effects of Notch signaling in bone homeostasis. Nat Med. 14:299–305. 2008. View Article : Google Scholar : PubMed/NCBI
33	Maeda K, Kobayashi Y, Udagawa N, et al: Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat Med. 18:405–412. 2012. View Article : Google Scholar : PubMed/NCBI
34	Al-Aly Z: Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opothy. Transl Res. 151:233–239. 2008. View Article : Google Scholar : PubMed/NCBI
35	Nie B, Zhou S, Fang X, Li W, Wang B and Guan S: Implication of receptor activator of NF-kappaB ligand in Wnt/beta-catenin pathway promoting osteoblast-like cell differentiation. J Huazhong Univ Sci Technolog Med Sci. 32:818–822. 2012. View Article : Google Scholar : PubMed/NCBI
36	Iso T, Hamamori Y and Kedes L: Notch signaling in vascular development. Arterioscler Thromb Vasc Biol. 23:543–553. 2003. View Article : Google Scholar : PubMed/NCBI
37	Morrow D, Scheller A, Birney YA, et al: Notch-mediated CBF-1/RBP-J{kappa}-dependent regulation of human vascular smooth muscle cell phenotype in vitro. Am J Physiol Cell Physiol. 289:C1188–C1196. 2005.
38	Shimizu T, Tanaka T, Iso T and Kurabayashi M: Notch signaling directly targets Msx2: possible role of notch signaling in osteogenic conversion of vascular smooth muscle cells and vascular calcification. Circulation. 118:S3682008.